Treatment of relapsed/refractory acute myeloid leukaemia in adults
Author:
Affiliation:
1. Division of Hematology, Oncology, and Transplantation Department of Medicine University of Minnesota Minneapolis MN USA
Publisher
Wiley
Subject
Hematology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.15077
Reference86 articles.
1. Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia.
2. Mobilization and elimination of FLT3‐ITD+ acute myelogenous leukemia (AML) stem/progenitor cells by plerixafor, G‐CSF, and sorafenib: phase I trial results in relapsed/refractory AML patients;Andreeff M.;Blood,2012
3. Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein
4. Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia
5. Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. S100A4 mediates the accumulation and functions of myeloid-derived suppressor cells via GP130/JAK2/STAT3 signaling in acute myeloid leukemia;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2025-01
2. The clinical efficacy of a daratumumab-based regimen in relapsed/refractory acute leukemia: a single-center experience;Annals of Hematology;2024-07-24
3. Azacitidine Post-transplant Maintenance Improves Disease Progression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome;Clinical Lymphoma Myeloma and Leukemia;2024-05
4. Survival benefit of maintenance therapy in AML: a retrospective study in Iran;2023-12-06
5. Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trial;Blood Advances;2023-10-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3